BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29844222)

  • 1. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.
    Schwarz UI; Gulilat M; Kim RB
    Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29844222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for comprehensive pharmacogenetic genotyping platforms.
    Lauschke VM; Ingelman-Sundberg M
    Pharmacogenomics; 2016 Jun; 17(8):917-24. PubMed ID: 27248710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
    Han SM; Park J; Lee JH; Lee SS; Kim H; Han H; Kim Y; Yi S; Cho JY; Jang IJ; Lee MG
    Clin Pharmacol Ther; 2017 Mar; 101(3):396-405. PubMed ID: 27727443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment.
    Drögemöller BI; Wright GE; Niehaus DJ; Emsley R; Warnich L
    Pharmacogenet Genomics; 2013 Dec; 23(12):666-74. PubMed ID: 24141736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing.
    Zhou Y; Koutsilieri S; Eliasson E; Lauschke VM
    Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):452-464. PubMed ID: 35971800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrogating Pharmacogenetics Using Next-Generation Sequencing.
    Ji Y; Shaaban S
    J Appl Lab Med; 2024 Jan; 9(1):50-60. PubMed ID: 38167765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
    Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
    Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug Therapy.
    Zhou Y; Lauschke VM
    Handb Exp Pharmacol; 2023; 280():237-260. PubMed ID: 35792943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and opportunities associated with rare-variant pharmacogenomics.
    Zhou Y; Tremmel R; Schaeffeler E; Schwab M; Lauschke VM
    Trends Pharmacol Sci; 2022 Oct; 43(10):852-865. PubMed ID: 36008164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics: Role of Single Nucleotide Polymorphisms.
    Yucesan E; Ozten N
    Methods Mol Biol; 2019; 2054():137-145. PubMed ID: 31482453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression.
    Tremmel R; Klein K; Battke F; Fehr S; Winter S; Scheurenbrand T; Schaeffeler E; Biskup S; Schwab M; Zanger UM
    Hum Genet; 2020 Feb; 139(2):137-149. PubMed ID: 31786673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling.
    Huebner T; Steffens M; Scholl C
    Mol Biol Rep; 2023 Nov; 50(11):9587-9599. PubMed ID: 37787843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Next-Generation Sequencing in Pharmacogenomics.
    Enko D; Michaelis S; Schneider C; Schaflinger E; Baranyi A; Schnedl WJ; Muller DJ
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.
    Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ
    Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
    Zhou Y; Lauschke VM
    Expert Rev Clin Pharmacol; 2024 Mar; 17(3):213-223. PubMed ID: 38247431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards population-specific pharmacogenomics in the era of next-generation sequencing.
    Ji X; Ning B; Liu J; Roberts R; Lesko L; Tong W; Liu Z; Shi T
    Drug Discov Today; 2021 Aug; 26(8):1776-1783. PubMed ID: 33892143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.